A Current View on New Cancer Drugs (2014-USFDA Approved) Over Old Drugs

International Journal of Novel Trends in Pharmaceutical Sciences,2015,5,5,198-208.
Published:October 2015
Type:Review Article
Authors:
Author(s) affiliations:

M. Sravan, M. Shankar*, R. Charan Kumar, M. Niranjan Babu

Department of Pharmaceutical Chemistry, Seven Hills College of Pharmacy, Tirupati-517561, Andhra Pradesh, India.

Abstract:

Cancer is also known as a malignant tumor, is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Not all tumors are cancerous, benign tumors do not spread to other parts of the body. Treatment options are depend on the stage and type of cancer. As compare to previous drugs the newly 2014 USFDA approved drugs work effectively in treating the cancer. The number of patients treated with new drugs such as Bevacizumab, Crizotinib, Pembrolizumab, Idelalisib was effectively against chronic lymphocytic leukemia patients without the need of chemotherapy and the treatment of pediatric osteosarcoma etc.

Downloads: 
In-page image(s): 

Cervical and uterus cancer